surmount 4 tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial SURMOUNT‐4 study design. This is

Compounded tirzepatide is a dual agonist, meaning it activates two hormonal receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor

170,171,172,173 Therapeutic implications for targeting NADPH metabolism Compared with their normal counterparts, many types of cancer cell have increased oxidative stress and the upregulation of antioxidant capacity

When an individual perceives danger, sympathetic neurons signal the adrenal glands to secrete norepinephrine and epinephrine

Malone Professor of Molecular, Cellular and Developmental Biology and professor of chemistry, of pharmacology, and of management at Yale University

For control, MRAB-3 biofilms were treated with 1 PBS